ADAMTS13, RECOMBINANT-KRHN: Who Reports Side Effects? Age, Gender & Country Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Gender Distribution
60.7%
Female
39.3%
Male
Age Information
The average age of patients reporting adverse events with ADAMTS13, RECOMBINANT-KRHN is 27.6 years.
Geographic Distribution
The majority of adverse event reports for ADAMTS13, RECOMBINANT-KRHN originate from US.
Report Summary & Outcomes
68
Total Reports
68
As Primary/Secondary Suspect
1
Deaths Reported
20
Hospitalizations
1
Life-Threatening
Reporting Timeline
First adverse event report: 20221201. Most recent report: 20250712. View full timeline →